Costa Rica approves Wegovy for weight loss; pricing and eligibility set

Costa Rica's health regulator has granted sanitary registration for Wegovy, a GLP-1 weight-loss drug, across five dosages. The approval expands access to a high-demand treatment in Central America, though pricing and reimbursement details remain unclear. This marks a notable regulatory milestone for the region's pharmaceutical market.